Kristen Rahn, Ph.D. - Publications
Affiliations: | 2009 | Pennsylvania State University, State College, PA, United States |
Area:
Neuroscience BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2011 | Rahn KA, McLaughlin PJ, Zagon IS. Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis. Brain Research. 1381: 243-53. PMID 21256121 DOI: 10.1016/J.Brainres.2011.01.036 | 0.475 | |||
2010 | Zagon IS, Rahn KA, Bonneau RH, Turel AP, McLaughlin PJ. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis. Brain Research. 1310: 154-61. PMID 19931226 DOI: 10.1016/J.Brainres.2009.11.026 | 0.493 | |||
2009 | Zagon IS, Rahn KA, Turel AP, McLaughlin PJ. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis. Experimental Biology and Medicine (Maywood, N.J.). 234: 1383-92. PMID 19855075 DOI: 10.3181/0906-Rm-189 | 0.49 | |||
2007 | Zagon IS, Rahn KA, McLaughlin PJ. Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells. Neuropeptides. 41: 441-52. PMID 17910895 DOI: 10.1016/J.Npep.2007.08.002 | 0.407 | |||
Show low-probability matches. |